California’s life science industry is a major economic driver for the state. It generates over 1 million jobs, continuously provides new innovations in health and has led the nation in NIH funding and venture capital for years. But the picture isn’t all rosy for the industry and pressures on today’s California life sciences companies, entrepreneurs and executive teams continue to mount.
The House Energy and Commerce Committee released the 21st Century Cures Initiative discussion draft, which includes a broad range of proposals meant to help accelerate the discovery, development, and delivery of new treatments and cures. Since April of 2014, the House Energy and Commerce Committee, under the leadership of Chairman Fred Upton (R-MI) and Diana DeGette (D-CO), has held dozens of panels, roundtables, and hearings on the comprehensive biomedical innovation ecosystem. Key stakeholders, including patients, industry, researchers, regulators, providers and biomedical trade associations such as BayBio, have provided information and ideas to help shape the proposals put forth in this draft.